Arena Of U.S. Seeks China, Europe Partners To Market Belviq Obesity Drug
This article was originally published in PharmAsia News
Executive Summary
U.S.-based Arena Pharmaceuticals says it is seeking partners in China and Europe to market its Belviq (lorcaserin), for treating obesity.